On Nov. 26, 2019, ChemoCentryx issued a press release announcing that the Advocate trial met both of its primary endpoints, saying Tavneos showed noninferiority of disease remission at 26 weeks and ...

RDS Game Traveler Deluxe carrying cases and travel bags are officially licensed by Nintendo and half the price of the sold-out first-party cases.